dactinomycin has been researched along with Rhabdomyosarcoma 2 in 22 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (9.09) | 18.2507 |
2000's | 12 (54.55) | 29.6817 |
2010's | 5 (22.73) | 24.3611 |
2020's | 3 (13.64) | 2.80 |
Authors | Studies |
---|---|
Calvão, J; Cardoso, JC; Figueiredo, A; Ramos, L | 1 |
Cai, X; Cao, S; Gao, X; Guo, W; Jia, Q; Liu, T; Tang, L; Wang, T; Wu, Z; Xiao, J; Yang, J | 1 |
Barthère, X; Guillerm, S; Hennequin, C; Itti, R; Le Maignan, C; Quero, L; Torossian, N; Verillaud, B | 1 |
Kamimura, S; Kinoshita, M; Miyachi, M; Moritake, H; Sawa, D; Yamada, A | 1 |
Choi, SM; Han, JS; Joo, JH; Park, IK; Shin, JH | 1 |
Adamkiewicz-Drozynska, E; Bien, E; Fatyga, A; Gabrych, A; Izycka-Swieszewska, E; Kazanowska, B; Krawczyk, MA; Kunc, M; Sokolewicz, EM; Styczewska, M | 1 |
Hura, SK; Kaur, N; Meshram, GG | 1 |
Anderson, JR; Arndt, CA; Donaldson, SS; Hawkins, DS; Lyden, ER; Morris, CD; Rodeberg, DA; Wolden, SL | 1 |
Capuano, AC; Gatti, A; Libório, TN; Mantesso, A; Nunes, FD; Pinto-Junior, DS | 1 |
Hayashi, Y; Hirato, J; Kuroiwa, M; Park, MJ; Sakamoto, J; Shimada, A; Sotomatsu, M; Suzuki, N | 1 |
Pappo, A; Paulino, AC | 1 |
Seregard, S | 1 |
Chen, C; Goldwein, JW; Maity, A; Shu, HK; Womer, RB | 1 |
Demarchi, GT; Freitas, RG; Macedo, A; Nobre, YT; Ortiz, V; Srougi, M | 1 |
Ishizaka, K; Kobayashi, S; Kobayashi, T; Machida, T; Oka, K; Oka, T; Ozeki, Z | 1 |
Ghosh, K; Khatua, S; Nair, CN | 1 |
Case, AS; Conner, MG; Huh, WK; Kirby, TO | 1 |
Kawakami, M; Kawase, K; Kobayashi, T; Morikawa, T; Nogi, H; Suzuki, M; Tabei, I; Toriumi, Y; Uchida, K | 1 |
Bowman, L; Gajjar, A; Jenkins, JJ; Kanwar, VS; Parham, DM; Ribeiro, RC | 1 |
Gardner, MO; Martin, D; Nicklaus, P; Winter, SS | 1 |
Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
Cizmić, A; Milanovic, R; Pajić, A; Zganjer, M | 1 |
4 review(s) available for dactinomycin and Rhabdomyosarcoma 2
Article | Year |
---|---|
Treatment strategies and outcomes for spinal rhabdomyosarcoma: A series of 11 cases in a single center and review of the literature.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Buttocks; Chemoradiotherapy, Adjuvant; Chemotherapy, Adjuvant; Child, Preschool; Cohort Studies; Cyclophosphamide; Dactinomycin; Female; Humans; Karnofsky Performance Status; Male; Middle Aged; Neurosurgical Procedures; Operative Time; Palliative Care; Prostatic Neoplasms; Retroperitoneal Neoplasms; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Survival Rate; Vincristine; Vulvar Neoplasms; Young Adult | 2020 |
Adult parameningial alveolar rhabdomyosarcoma: Case report and literature review.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Middle Aged; Nose Neoplasms; Radiotherapy, Intensity-Modulated; Rhabdomyosarcoma, Alveolar; Vincristine | 2020 |
Rhabdomyosarcoma of the Gluteus Maximus - Case Report, Review of Literature and Emerging Therapeutic Targets.
Topics: Antineoplastic Combined Chemotherapy Protocols; Buttocks; Child, Preschool; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Humans; Rhabdomyosarcoma, Alveolar; Vincristine | 2019 |
Volumetric considerations in radiotherapy for pediatric parameningeal rhabdomyosarcomas.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Combined Modality Therapy; Cranial Irradiation; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Doxorubicin; Etoposide; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Ifosfamide; Life Tables; Male; Nasopharyngeal Neoplasms; Neoplasm Staging; Pennsylvania; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Retrospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2003 |
1 trial(s) available for dactinomycin and Rhabdomyosarcoma 2
Article | Year |
---|---|
Local Control for Intermediate-Risk Rhabdomyosarcoma: Results From D9803 According to Histology, Group, Site, and Size: A Report From the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease Progression; Disease-Free Survival; Female; Humans; Infant; Lymph Nodes; Male; Meningeal Neoplasms; Radiotherapy Dosage; Retroperitoneal Neoplasms; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Topotecan; Treatment Failure; Tumor Burden; Vincristine | 2015 |
17 other study(ies) available for dactinomycin and Rhabdomyosarcoma 2
Article | Year |
---|---|
Primary cutaneous alveolar rhabdomyosarcoma in an adolescent - A challenging diagnosis.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Humans; Ifosfamide; Male; Positron-Emission Tomography; Rhabdomyosarcoma, Alveolar; Skin Neoplasms; Vincristine | 2020 |
Successful treatment of metastatic alveolar rhabdomyosarcoma with MGMT gene promoter methylation by temozolomide-based combination chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Camptothecin; Chemoradiotherapy; Child, Preschool; Cyclophosphamide; Dacarbazine; Dactinomycin; DNA Methylation; DNA Modification Methylases; DNA Repair Enzymes; DNA, Neoplasm; Humans; Irinotecan; Male; MicroRNAs; Neoplasm Metastasis; Promoter Regions, Genetic; Rhabdomyosarcoma, Alveolar; RNA, Neoplasm; Temozolomide; Tumor Suppressor Proteins; Vincristine | 2018 |
One-year survivor of adult alveolar rhabdomyosarcoma of the maxillary sinus with orbital extension: Case report.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; Female; Humans; Maxillary Sinus; Maxillary Sinus Neoplasms; Orbit; Orbital Neoplasms; Radiotherapy Dosage; Rhabdomyosarcoma, Alveolar; Vincristine; Young Adult | 2018 |
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2019 |
Asymptomatic expansile lesion in the nasolabial region of a 10-year-old child.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child; Cranial Irradiation; Cyclophosphamide; Cysts; Dactinomycin; Diagnosis, Differential; Female; Humans; Mouth Mucosa; Mouth Neoplasms; Nasal Mucosa; Nose Neoplasms; Rhabdomyosarcoma, Alveolar; Ultrasonography; Vincristine | 2009 |
Manifestation of alveolar rhabdomyosarcoma as primary cutaneous lesions in a neonate with Beckwith-Wiedemann syndrome.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Beckwith-Wiedemann Syndrome; Bone Marrow Transplantation; Camptothecin; Cyclophosphamide; Dactinomycin; Humans; Immunohistochemistry; In Situ Hybridization, Fluorescence; Infant, Newborn; Irinotecan; Potassium Channels, Voltage-Gated; Rhabdomyosarcoma, Alveolar; Skin Neoplasms; Transcription, Genetic; Vincristine | 2009 |
Alveolar rhabdomyosarcoma of the extremity and nodal metastasis: Is the in-transit lymphatic system at risk?
Topics: Antineoplastic Combined Chemotherapy Protocols; Benzenesulfonates; Camptothecin; Child; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dactinomycin; Etoposide; Fatal Outcome; Female; Foot; Groin; Humans; Ifosfamide; Irinotecan; Lymph Node Excision; Lymphatic Metastasis; Lymphatic System; Male; Niacinamide; Phenylurea Compounds; Pyridines; Radiotherapy, Adjuvant; Radiotherapy, High-Energy; Rhabdomyosarcoma, Alveolar; Salvage Therapy; Soft Tissue Neoplasms; Sorafenib; Temozolomide; Thigh; Vincristine | 2009 |
Management of alveolar rhabdomyosarcoma of the orbit.
Topics: Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Doxorubicin; Female; Humans; Ifosfamide; Infant; Magnetic Resonance Imaging; Ophthalmologic Surgical Procedures; Orbital Neoplasms; Rhabdomyosarcoma, Alveolar; Vincristine | 2002 |
Continent urinary reconstruction in rhabdomyosarcoma: a new approach.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Child; Child, Preschool; Colon, Transverse; Colonic Pouches; Combined Modality Therapy; Cyclophosphamide; Cystectomy; Dactinomycin; Fatal Outcome; Female; Follow-Up Studies; Humans; Infant; Male; Prostatic Neoplasms; Radiotherapy, Adjuvant; Rhabdomyosarcoma; Rhabdomyosarcoma, Alveolar; Sepsis; Urethral Neoplasms; Urinary Bladder Neoplasms; Urinary Catheterization; Urinary Diversion; Urinary Tract Infections; Urogenital Neoplasms; Vaginal Neoplasms; Vincristine | 2004 |
[Alveolar rhabdomyosarcoma originating in spermatic cord: a case report].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Dactinomycin; Drug Administration Schedule; Genital Neoplasms, Male; Humans; Ifosfamide; Male; Orchiectomy; Rhabdomyosarcoma, Alveolar; Spermatic Cord; Vincristine | 2004 |
Immune-mediated thrombocytopenia following dactinomycin therapy in a child with alveolar rhabdomyosarcoma: the unresolved issues.
Topics: Autoantibodies; Blood Platelets; Child; Dactinomycin; Humans; Immunoglobulin G; Male; Platelet Count; Rhabdomyosarcoma, Alveolar; Thrombocytopenia | 2004 |
A case report of rhabdomyosarcoma of the uterus associated with uterine inversion.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cyclophosphamide; Dactinomycin; Female; Humans; Rhabdomyosarcoma, Alveolar; Uterine Inversion; Uterine Neoplasms; Vincristine | 2005 |
Primary rhabdomyosarcoma of the breast in a 13-year-old girl: report of a case.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Breast Neoplasms; Dactinomycin; Doxorubicin; Fatal Outcome; Female; Humans; Ifosfamide; Lung Neoplasms; Mastectomy; Rhabdomyosarcoma, Alveolar | 2007 |
Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases.
Topics: Child; Child, Preschool; Dactinomycin; Drug Eruptions; Female; Humans; Male; Rhabdomyosarcoma, Alveolar | 1995 |
Rhabdomyosarcoma treated with chemotherapy during the third trimester.
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Female; Humans; Magnetic Resonance Imaging; Neoplasm Staging; Paranasal Sinus Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Remission Induction; Rhabdomyosarcoma, Alveolar; Vincristine | 1997 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Rhabdomyosarcoma of the hand.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Dactinomycin; Female; Hand; Humans; Ifosfamide; Prognosis; Rhabdomyosarcoma, Alveolar; Treatment Outcome; Vincristine | 2001 |